Dr. Jecker collaborates with colleagues throughout Asia, sub-Saharan Africa, and Europe.
- Japanese Society for the Promotion of Science International Fellow (2018)
- Visiting Professor at the National University of Singapore (2018)
- Scholar-in-residence at the Brocher Foundation (2017)
- Visiting Professor at The University of Bucharest Research Institute (2017)
- Visiting Professor at the Chinese University of Hong Kong (2017)
- Keynote speaker at the Israeli Ministry of Health (2017)
Dr. Jecker was recently awarded a Rockefeller Foundation Fellowship at the Bellagio Center, Como, Italy (2020).
Dr. Jecker serves on the Board of Directors for the International Association of Bioethics (elected 2019).
Dr. Fullerton's work on equity, diversity and inclusion centers on health disparities, specifically as it relates to genomics and precision medicine.
Publications (last 12 months only):
Umeukeje, E, Young, B, Fullerton, SM, Cavanaugh, K, Owens, D, Wilson, JG, Burke, W, & Blacksher E (2019). You are just now telling us about this? African American perspectives on testing for genetic susceptibility to kidney disease. Journal of the American Society of Nephrology, 30(4): 526-530 [original work].
Lee, SSJ, Fullerton, SM, Saperstein, A, & Shim, J (2019). The ethics of inclusion: cultivating trust in precision medicine. Science, 64(6444): 941-942 [commentary].
Young, BA, Blacksher, E, Cavanaugh, KL, Freedman, BI, Fullerton, SM, Kopp, JB, Umeukeje, EM, West, KM, Wilson, JG, & Burke, W, for the APOL1 Stakeholders Project (2019). APOL1 testing in African Americans: involving the community in policy discussions. American Journal of Nephrology, 50(4): 303-311 [original work].
Callier, S, & Fullerton, SM (in press). Diversity and inclusion in unregulated mHealth research: addressing the risks. Journal of Law, Medicine, and Ethics [commentary].
2U24 HG007307-05 Jarvik/Veenstra/Nickerson/Fullerton/Tarczy-Hornoch (MPI), Evolving our Partnership: The CSER2 Centralized Support Coordinating Center, 8/1/17 - 6/30/21, Role: MPI
1R01 HG010330-01 Lee/Shim (MPI), Ethics of Inclusion: Diversity and Social Justice in Precision Medicine Research, 9/20/18 - 6/30/22, Role: Subcontract PI
5U01 HL120393-04 Psaty/Rice/Rich (MPI), Trans-Omics for Precision Medicine (TOPMed) Data Coordinating Center (DCC), 4/1/14 - 4/30/23, Role: CoI (ELSI Committee Co-Chair)
"Aiming for equity: the ethical case for greater diversity in genomic research participation", presentation for "Diversity Matters: Scientific and Ethical Strategies for Achieving Representation in Genomics" Invited Session, American Society of Human Genetics Annual Meeting, Orlando, FL, October 2017
“Health care disparities in genomic medicine”, for the National Academies of Sciences, Engineering, and Medicine, Roundtable on Genomics and Precision Health Fall 2017 Meeting, Washington, DC, November 2017
“Precision medicine for all: why diversity and inclusion matter for the genome sciences”, Occidental College Biochemistry Alumni Lecture, Los Angeles, CA, September 2018
“Consumer genomics: diversity and potential for disparities”, Exploring the Current Landscape of Consumer Genomics Workshop, National Academies of Sciences, Engineering, and Medicine, Roundtable on Genomics and Precision Health, Washington, DC, October 2019
Chair Special national service:
2018 Member, NHGRI Special Emphasis Panel, ZHG1 HGR-M M3: Initiative to Maximize Research Education in Genomics: Diversity Action Plan (DAP) (R25)
2018 Member, Planning Committee, National Academies of Sciences, Engineering, and Medicine Roundtable on Genomics and Precision Health, Workshop on Understanding Disparities in Access to Genomic Medicine, June 27, Washington, DC
2019-present Member, Steering Committee, Vanderbilt-Miami-Meharry Precision Medicine and Health Disparities Collaborative (PMHDC)
SOC WL 591 Embodiment of Risk, Health Disparities, and Stress Mechanisms (Nurius): Explanation or Intervention?
Ethical Perspectives on Health Disparities Research (2012 to present) GEN ST 391K Jump-Start Yours
For Incoming Community College Transfer Students (Harris): Research Ethics – Responsible Conduct of Research (2016 to present)
2013-2014 Samantha Torres (Public Health Genetics MPH), Chair 2011-2015 Mercy Laurino (Public Health Genetics PhD)
Dr. Campelia's research intersects with feminist bioethics and often attends to marginalized identities and experiences in medicine.
Dr. Roberto Montenegro and Dr. Campelia published "Ongoing Obstacles to Confronting Microaggressions in Medicine", PM&R Sep 2019. You can find more of this work here.
Dr. Campelia is the Ethics Theme Director in a course for medical students at the UW School of Medicine called The Ecology of Health and Medicine, which addresses EDI-related goals in medical school curriculum.
Additionally, Dr. Campelia has been involved in multiple professional organizations that focus on equity, diversity and inclusion: currently a member of the International Network of Feminist Approaches to Bioethics and the Association of Feminist Ethics & Social Theory (FEAST).
Dr. Campelia is also committed to EDI service, including work as a member on the Equity, Diversity, and Inclusion Faculty Development Steering Committee at the UW School of Medicine.
Dr. Campelia currently chairs the Equity, Diversity, and Inclusion Committee in the UW Department of Bioethics & Humanities.
Ms. Trinidad's empirical bioethics research and current doctoral studies center on community engagement, with a particular focus on the ethics and praxis of community-engaged health research with Alaska Native and American Indian communities. Much of her research has been conducted in partnership with tribal health organizations serving Alaska Native people in southcentral and southwest Alaska, as well as the Confederated Salish and Kootenai Tribes of Montana. Ms. Trinidad is a member of Community-Campus Partnerships for Health and the Academy of Communication in Healthcare.
Relevant publications (past 5 years):
Dorfman EH, Trinidad SB, Morales CT, Howlett K, Burke W, Woodahl EL. Pharmacogenomics in context: acceptability and feasibility in rural and tribal community settings. Pharmacogenomics. 2015;16(3):227-37. PMCID: PMC4360986
Trinidad SB, Ludman EJ, Hopkins S, James RD, Hoeft TJ, Kinegak A, Lupie H, Kinegak R, Boyer BB, Burke W. Community dissemination and genetic research: moving beyond results reporting. Am J Med Genet A. 2015;167(7):1542-50. PMCID: PMC4478235
Morales C, Muzquiz L, Azure B, Bodnar B, Finley V, Incashola T, Mathias C, Laukes C, Beatty P, Trinidad SB, James R, Burke W, Pershouse M, Putnam E, Woodahl E. Partnership with the Confederated Salish and Kootenai Tribes: establishing an advisory committee for pharmacogenetic research. Prog Community Health Partnersh, 2016 Summer;10(2):169-70. PMCID: PMC5015644
Hiratsuka VY, Avey JP, Trinidad SB, Beans JA, Robinson RF. Views on electronic cigarette use in tobacco screening and cessation in an Alaska Native healthcare setting. Int J of Circumpolar Health. 2015;74:27794. PMCID: PMC4612470
Avey JP, Hiratsuka VY, Trinidad SB, Tyndale RF, Robinson RF. Perceptions of pharmacogenetic research to guide tobacco cessation by patients, providers and leaders in a tribal healthcare setting. Pharmacogenomics. 2016; 17(4):405-15. PMCID: PMC5558512
Hiratsuka VY, Trinidad SB, Avey J, Robinson RF. Application of the PEN-3 model on tobacco initiation, use, and cessation among American Indian and Alaska Native adults. Health Promot Pract. 2016 May 13; 17(4):471-81. PMCID pending.
Trinidad SB, Shaw JL, Dirks L, Ludman EJ, Burke W, Dillard DA. Perceptions of alcohol misuse among Alaska Native healthcare system stakeholders: a qualitative exploration. J Ethn Subst Abuse. 2019 Feb 4:1-24. doi: 10.1080/15332640.2018.1556766. [epub ahead of print]
Hiratsuka VY, Trinidad SB, Ludman EJ, Shaw JL, Burke W, Robinson RF, Dillard DA. “You actually view us as the experts in our own system”: Indigenous-academic community partnership. Progress in Community Health Partnerships. [accepted Nov 22, 2019]
EDI-Related Funded Research (selected):
1S06GM127911-01, Ferucci (PI), Avey (project PI), 09/06/2018 – 07/31/2022, Cultural Innovations for Recovery in Community-based Learning Circles (NARCH 10): The CIRCLE project is part of the Alaska Native Tribal Health Consortium/ Southcentral Foundation Native American Research Center for Health (NARCH). We are developing a culturally grounded smartphone app to support Alaska Native and American Indian people in recovery from alcohol use disorder, incorporating peer support and community reinforcement approaches into a treatment modality that is feasible for use in rural settings in Alaska. As a co-investigator, I am contributing to study design, qualitative analysis of stakeholder input regarding design and implementation preferences, software specification development, and dissemination.
R01 HG009500, Hiratsuka (PI), 9/05/2017 – 6/30/2020, Community-engaged Research Toward Precision Medicine with American Indian Alaska Native People: This study will identify principles and approaches that can provide the foundation for effective precision medicine research (PMR) in American Indian/Alaska Native (AIAN) communities. In collaboration with our AIAN Community Advisory Groups, we will conduct empiric data collection from stakeholders at each study site; convene local dialogs with tribal leadership at each site and cross-site deliberation to discuss key issues; develop a communication plan to chart key messages, audiences, and communication vehicles; and convene a national meeting to identify areas of consensus and challenges to be overcome in implementing PMR in AIAN communities. As a co-investigator, I am contributing to data collection, analysis, and dissemination.
1S06 GM123545-01, Hiratsuka (PI), 09/15/2017 – 07/31/2021, Population-based Interventions to Improve Behavioral Health in a Tribal Healthcare System (NARCH 9): The Faculty Development Core of the Southcentral Foundation Native American Research Center for Health (NARCH IX) will evaluate and enhance the clinical and translational research skills of individual researchers; build writing skills and publication records; and improve lay dissemination. As a co-investigator, I serve as a writing coach and consultant and assist/advise in manuscript preparation and community outreach/education.
U26 1 IHS0079-01-00, Dillard (PI), 9/15/2013 – 9/14/2019, Southcentral Foundation Research Center for Alaska Native Health (2013 NARCH 7): This Native American Research Center for Health (NARCH) addresses the role of pharmacogenetics in interventions to promote tobacco cessation and sobriety in the Alaska Native and American Indian community in Southeast Alaska. I am developing human subjects protection plans, participating in qualitative design and analysis, aiding in survey development, and participating in dissemination activities. I am also serving as a peer mentor to qualitative researchers at the Southcentral Foundation, an Alaska Native owned and operated healthcare corporation based in Anchorage.
P01 GM116691-01, Thummel /Burke (MPI), 8/1/2016 – 7/30/2021, Program on Genetic and Dietary Predictors of Drug Response in Rural and AI/AN Populations: This program is based in a research partnership comprising the Universities of Washington, Montana, and Alaska (Fairbanks); Group Health Research Institute; and three tribal organizations, Southcentral Foundation (Anchorage, AK), the Confederated Salish and Kootenai Tribes (Flathead Reservation, MT), and the Yukon-Kuskokwim Health Corporation (Bethel, AK). We are investigating the role of gene-environment-drug and polygenic-drug interactions in Alaska Native and American Indian people. I am an investigator in the Partnership Core, which is focusing on developing knowledge about and procedures to support bi-directional capacity development; return of research results to participants and communities; and data sharing. My role includes qualitative research design/conduct/analysis, curriculum development, and communication support.
Dr. Dudzinski published a 2018 essay titled "White Privilege and Playing It Safe" and was later interviewed by the UW Medicine Newsroom about this topic.
Lang, KR, CY Dupree, AA Kon, DM Dudzinski. 2016. Calling Out Implicit Racial Bias as a Harm in Pediatric Care. Cambridge Quarterly of Healthcare Ethics. 25:3, 540-52;
Dudzinski, DM. White privilege & Playing it Safe. Bioethics.net blog. April 11, 2018. http://www.bioethics.net/2018/04/white-privilege-playing-it-safe/
Commentary: Playing it Safe; UW Medicine Newsroom: https://newsroom.uw.edu/postscript/commentary-white-privilege-and-playin...
Dudzinski, DM. 2018. White privilege & Playing it Safe. American Journal of Bioethics. 18:1, 4-5.
Dudzinski, DM. 2013. Ethics Committees and Consultants at Work. Case: Methamphetamine Addiction and Medical Futility. “In the Interest of Fairness” Cambridge Quarterly of Healthcare Ethics 22, 401-402.
Campelia, G, J. Kirkpatrick, J. Shirley, DM Dudzinski. Discharging to the Street: When Homeless Patients Refuse Safer Options. American Society for Bioethics & Humanities Annual Meeting, Pittsburgh, PA. October 26, 2019.
Lang, KR, AA Kon, CY Dupree, DM Dudzinski. “Pediatric Care Providers are Color-Blind” and Other White Lies: The Impact of Implicit Bias and Unconscious Racism on the Care of Children. American Society for Bioethics and Humanities Annual Meeting, San Diego, California. October 18, 2014
Brazg, T and DM Dudzinski. What Does it Mean to Advocate for a Vulnerable Patient in Ethics Consultation? Who Should Do It? International Clinical Ethics Consultation Conference. Paris, France. April 22, 2014
Presenter & Member of Program Committee, The Ethical & Policy Implications of Limiting Growth in Children with Severe Disabilities Symposium. University of Washington Disability Studies Program & Treuman Katz Center for Pediatric Bioethics, May 16, 2007
Professional Development & Diversity Training (select): Implicit Bias Training, Institute of Translational Health Sciences (ITHS), half day, University of Washington, 2017 UW Medicine Leadership Retreat, Diversity, Equity & Inclusion: Quality of Conditions in the Learning Environment, May 2018 National Coalition Building Institute: Leadership for Diversity, day-long training, Seattle, Washington June 19, 2019 Diversity Leadership Symposium, Center for Equity, Diversity, & Inclusion (UW SOM), half-day, Seattle, Washington, December 11, 2019
Dr. Kirkpatrick's most recent publication in support of the department's mission of "Health through Social Justice" is:
Campelia GD, Barg FK, Kirkpatrick JN, Hull SC. Care Labor in VAD Therapy: Some Feminist Concerns. Perspect Biol Med. 2019;62(4):640-656. doi: 10.1353/pbm.2019.0037. PMID: 31761798
Dr. Sullivan recently completed an investigation into social roots of opioid epidemic linking opioid prescribing, opioid deaths and opioid hospitalizations in Washington with social determinants (education, race, unemployment, etc.) at the zipcode level using data from the WA Department of Health.
Dr. Blacksher's career in bioethics has focused on conceptual, ethical, and empiric questions raised by systematic differences in health outcomes associated with class and race. In addition to her normative scholarship, Dr. Blacksher designs and implements deliberative engagements in collaboration with populations burdened by excess disease to address questions of relevance to them.
Dr. Blacksher published Shrinking Poor White Life Spans: Class, Race, and Health Justice as a target article for The American Journal of Bioethics, which attracted 10 commentaries and earned her an invitation to present at the National Academies of Science's Committee on Rising Midlife Mortality Rates and Socioeconomic Disparities.
She was invited to present as distinguished faculty at the 2018 American Society of Nephrology Kidney Week: Racial Inequalities in Kidney Diseases: Connecting Social Factors to Genetic Risk for her work on APOL1 gene variants and racial disparities in kidney disease.
In 2019, Dr. Blacksher was an invited research group member for The Hastings Center's "How Should the Public Learn? Reconstructing Common Purpose and Civic Innovation for a Democracy in Crisis," and invited to contribute to The Hastings Center Report “Reckoning with Whiteness and Renewing Our Capacities for Civic Listening and Learning in a Polarized and Unhealthy America.”
Select Invited Lectures:
“Concepts of Whiteness and Midlife Mortality Rates and Socioeconomic Disparities.” Presentation to Committee on Rising Midlife Mortality Rates and Socioeconomic Disparities. National Academies of Science. Washington, D.C. July 18, 2019.
“Health Justice at the Intersection of Class and Race: Concepts of Whiteness and Longevity Loss in Low Education White People” The Hopkins Center for Health Disparities Solutions. The Johns Hopkins University. Baltimore, MD. December 9, 2019.
“White Privilege, White Poverty: Barriers to and Opportunities for Civic Learning and Democratic Discourse in a Polarized America.” Research Project Workgroup Member. How Should the Public Learn? Reconstructing Common Purpose and Civic Innovation for a Democracy in Crisis. The Hastings Center. Garrison, NY. November 15-18, 2018.
“Challenges to Talking About APOL1 Gene Variants and Racial Disparities in Kidney Disease,” Racial Inequalities in Kidney Diseases: Connecting Social Factors to Genetic Risk (Distinguished Faculty). American Society of Nephrology Kidney Week 2018. San Diego, CA. October 27, 2018.
“LBJ’s (Not So) Great Society After Fifty Years: A (Poor) Health Legacy.” Medical Center Hour. University of Virginia School of Medicine. Charlottesville, Virginia. February 11, 2015.
Blacksher E. Shrinking Poor White Life Spans: Class, Race, and Health Justice. American Journal of Bioethics (target article, 10 commentaries) 2018;18(10):3-14. doi:10.1080/15265161.2018.1513585
Blacksher E. 2018. Public Health and social justice: An argument against stigma as a tool of health promotion and disease prevention. In The Handbook of Stigma, Discrimination and Health, Link B, Dovidio J, Major B., eds. New York, NY: Oxford University Press.
Umeukeje E, Young B, Fullerton SM, Cavanaugh K, Owens D, Wilson JG, Burke W, Blacksher E. You Are Just Now Telling Us About This? African American Perspectives on Testing for Genetic Susceptibility to Kidney Disease. Journal of the American Society of Nephrology 2019;30(4):526-530. doi: 10.1681/ASN.2018111091 (selected as part of “Best of JASN” 2019 ASN conference)
Blacksher E. 2016. Obesity Prevention in Children: Media Campaigns, Stigma, and Ethical Considerations (Case Study). Public Health Ethics: Cases Spanning the Globe, Barrett DH, Ortmann LH, Dawson A, Saenz C, Reis A, Bolan G, eds. New York, NY: Springer International Publishing. Available online at: http://www.springer.com/us/book/9783319238463
Blacksher E, Goold SD. 2016. Black-White Infant Mortality: Disparities, Priorities, and Social Justice in Public Health (Case Study). Public Health Ethics: Cases Spanning the Globe. Barrett DH, Ortmann LH, Dawson A, Saenz C, Reis A, Bolan G, eds. New York, NY: Springer International Publishing. Available online at: http://www.springer.com/us/book/9783319238463
Blacksher E, Nelson C, Van Dyke ER, Bassett D, Echo-Hawk AL, Buchwald DS. Conversations about Community-Based Participatory Research and Trust: “We Are Explorers Together” Prog Community Health Partnersh 2016;10(2):305-9. PMID: 27346777. DOI: 1353/cpr.2016.0039.
Blacksher E. Redistribution and Recognition: Pursuing Social Justice in Public Health. Cambridge Quarterly of Healthcare Ethics 2012;21(3):1-12. PMID:22624535. DOI:10.1017/S0963180112000047.
Blacksher E. On Being Poor and Feeling Poor: Low SES and the Moral Self. Theoretical Medicine and Bioethics 2002;23(6):455-470.